The Patent Finder

Novaremed Ltd.

Also on record
Records under this name other than the patents Novaremed Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Showing 1 to 9 of 9 · Back to Novaremed Ltd.

PatentTitleStatus Expires Confidence
US 8,802,734Method of Treating or Preventing Pain
Lapsed on the fee record
Ended Aug 12, 2026 · Medium confidence
Lapsed on the fee recordEnded Aug 12, 2026Medium confidence
US 8,252,843Compounds for the treatment of AIDS and other viral diseases
Lapsed on the fee record
Ended Aug 28, 2024 · From the USPTO record
Lapsed on the fee recordEnded Aug 28, 2024From the USPTO record
US 9,199,917N-substituted benzenepropanamide or benzenepropenamide derivatives for use in the treatment of pain and inflammation
Lapsed on the fee record
Ended Dec 1, 2023 · From the USPTO record
Lapsed on the fee recordEnded Dec 1, 2023From the USPTO record
US 9,133,103N-substituted benzenepropanamide and benzenepropenamide for use in the prevention or the treatment of affective disorders
Lapsed on the fee record
Ended Sep 15, 2023 · From the USPTO record
Lapsed on the fee recordEnded Sep 15, 2023From the USPTO record
US 8,309,606Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
Term ended
Term ended Aug 18, 2023 · From the USPTO record
Term endedTerm ended Aug 18, 2023From the USPTO record
US 8,883,853N-substituted benzenepropanamide or benzenepropenamide derivatives for use in the treatment of pain and inflammation
Lapsed on the fee record
Ended Nov 11, 2022 · From the USPTO record
Lapsed on the fee recordEnded Nov 11, 2022From the USPTO record
US 7,754,771Compounds for the treatment of AIDS and other viral diseases
Lapsed on the fee record
Ended Jul 13, 2022 · From the USPTO record
Lapsed on the fee recordEnded Jul 13, 2022From the USPTO record
US 7,674,829Compounds for the treatment of AIDS and other viral diseases
Lapsed on the fee record
Ended Mar 9, 2022 · From the USPTO record
Lapsed on the fee recordEnded Mar 9, 2022From the USPTO record
US 7,642,290Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
Lapsed on the fee record
Ended Jan 5, 2022 · From the USPTO record
Lapsed on the fee recordEnded Jan 5, 2022From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited